Travere Therapeutics, Inc.
Travere Therapeutics, Inc.（TVTX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
tvtx · 股价预测 · 18 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 18 位华尔街分析师
Buy
18 位分析师
共识
评级分布
12 个月目标价
High
$67.00
Consensus
$56.67
+19.7% upside
Low
$49.00
Median: $54 · Last Close: $47.35
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$56.67
19.7% upside
High Target
$67
41.5%
Low Target
$49
3.5%
Current Price
$47.35
as of today
Based on analyst price targets, the TVTX stock price prediction for the next 12 months ranges from $49 to $67. The consensus TVTX price forecast of $56.67 implies 19.7% upside from the current price of $47.35.
短期股价预测
Bull算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $48.02 | ↑ 1.42% |
1-day model range: $47.75–$48.29. Peak: $48.29 (+1.42%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $85 | +80.0% |
| 2028 | $126 | +166.4% |
| 2029 | $162 | +243.1% |
| 2030 | $191 | +302.4% |
| 2031 | — | +344.1% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · TVTX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-03 | Citigroup | Maintains | Buy→Buy |
| 2026-06-03 | Wedbush | Maintains | Outperform→Outperform |
| 2026-06-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-06 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-05-05 | Wedbush | Maintains | Outperform→Outperform |
| 2026-05-05 | Citigroup | Maintains | Buy→Buy |
| 2026-05-05 | TD Cowen | Maintains | Buy→Buy |
| 2026-05-05 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-24 | Guggenheim | Maintains | Buy→Buy |
| 2026-04-14 | Citigroup | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Travere Therapeutics, Inc. (TVTX) stock. Of the recent 132 rating actions, 4 were upgrades and 4 were downgrades. 18 analysts currently cover TVTX.
分析师推荐趋势
TVTX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$700M
↓ 40.8% YoY
Revenue Next Year
$970M
↑ 38.6% YoY
EPS This Year
$0.23
EPS Next Year
$2.52
↑ 985.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast TVTX EPS of $0.23 for the current fiscal year, based on estimates from 8 analysts. The TVTX revenue forecast is $700M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
TVTX 股价预测由两类独立数据源支撑：来自 18 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。TVTX 的共识目标价为 $56.67（+19.7% 上行空间），分析师共识为 Buy。
TVTX 的短期预测（明日）为 $48.02（+1.42%）。 TVTX 对 2027 年的股价预测均值为 $85。 TVTX 对 2030 年的预测区间为 $179–$202。
Travere Therapeutics, Inc. 在 NASDAQ 上市，代码 TVTX。TVTX 在 2027 年的整体展望偏积极，在覆盖分析师中约 83% 对应 Buy 共识。
常见问题
TVTX 预测 · 8 个问题根据 18 位华尔街分析师，TVTX 的 12 个月平均目标价为 $56.67，最高 $67.00、最低 $49.00。若有图表，中位目标价可在上方查看。相对当前价 $47.35，隐含约 +19.7% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.